Study of Mepolizumab Safety Syringe in Asthmatics
NCT03021304
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Mepolizumab
Sponsor
GlaxoSmithKline